Anelia Bet’s Post

Did you hear? #Natera has over 200 peer-reviewed publications! And approximately 40 of those publications feature Natera’s organ health products, including data from ProActive, the largest prospective donor-derived cfDNA study in kidney transplantation, and data from RenaCARE, a large, multisite, real-world, prospective study assessing the frequency and impact of genetic testing in chronic kidney disease. Way to go, team! #Natera https://ow.ly/3EQK30sFnNs

Research Article Clinical Improvement in Early-Onset Interstitial Lung Disease Using Rituximab in Children With Antimelanoma Differentiation-Associated Gene 5–Positive Juvenile Dermatomyositis 📰 https://lnkd.in/gwjXHjzE #interstitiallungdisease #juveniledermatomyositis

An easy-to-use prediction classification system (the CROSS model) could aid in the early detection patients anti-melanoma differentiation-associated gene 5 positive #dermatomyositis (anti-#MDA5+) who have a high risk to develop rapidly progressive interstitial lung disease (RP-ILD). This model uses clinical variables that could be easily obtained during the routine clinic visit, and based on the CROSS score (range from 0 to 6), anti-MDA5+DM patients were classified as moderate risk (CROSS score = 0-2), high risk (CROSS score = 3-4), and very high risk (CROSS score = 5-6) for developing of RP-ILD, respectively. 🔗https://lnkd.in/dQMHDseY

Genomic medicine in GI disorders: Discussing the role of genetic testing and biomarker profiling in predicting disease, #prognosis, and treatment response in conditions such as colorectal cancer and familial polyposis #syndromes. #Pharmacogenomics: Highlighting the impact of genetic variations on drug metabolism and efficacy, and the potential for personalized medication regimens in inflammatory bowel disease and #hepatitis C For more details: https://lnkd.in/gUM3caRJ #gastroentrology #gastrocongress2024 #Hepatology #confrence #liverdisease #alimentarycanal

Researchers discovered seven genetic variants that may be associated with surgical rhizarthrosis and three variants that appear to be associated with nonsurgical rhizarthrosis. It emphasized that identifying genetic differences between these patient groups could reveal biological pathways influencing various features of rhizarthrosis. While no solid conclusions about the effect of specific genetic variants on the need for surgical treatment should be made at this stage, the study marks a stride towards integrating genetic insights into the clinical management of osteoarthritis, with the long-term aim of refining diagnosis, treatment, and preventative strategies for this common and debilitating disease. #genetics #osteoarthritis #clinicalmanagement #rhizarthrosis

Did you know Ambry's Patient for Life program isn't just for exome testing? Neurological panels like NeurodevelopmentNext™ and EpilepsyNext-Expanded™ also qualify for proactive analysis to account for new gene disease associations, providing updated diagnoses to patients who receive expanded neurogenetics panels at Ambry. Genetic Counselor Victoria Suslovitch shares how one patient with a ZBTB20 mutation received answers. #PatientforLife #neurogenetics #AmbryKnowsGenes

Did you know Ambry's Patient for Life program isn't just for exome testing? Neurological panels like NeurodevelopmentNext™ and EpilepsyNext-Expanded™ also qualify for proactive analysis to account for new gene disease associations, providing updated diagnoses to patients who receive expanded neurogenetics panels at Ambry. Genetic Counselor Victoria Suslovitch shares how one patient with a ZBTB20 mutation received answers. #PatientforLife #neurogenetics #AmbryKnowsGenes

By utilizing a reliable and comprehensive risk prediction model, pedigree-based family history, individual PRS, and molecular genetic analysis results can be combined easily, enabling the calculation of personalized BC risks and allowing for an improved clinical management in BC prevention: t.ly/i4i5P #RBCBioscience #Research #diagnostics #DNA #breast #cancer #genetic #hereditary 

#ProstateCancerAwarenessMonth is the time to highlight the importance of early detection and personalized care. Genetic tests, like Prolaris®, can provide valuable insights into a patients specific cancer helping patients and doctors tailor treatment plans to each individual’s unique situation. Knowledge is power! Learn how Prolaris is impacting real patients lives https://brnw.ch/21wMx1f #prostatecancer #genetictesting #biomarkers

Good pc of info